ACCUVANCE LLP
Founded in 2021
About ACCUVANCE LLP
Accuvance LLP specializes in offering innovative bioscience solutions and advanced assisted reproductive technology to dairy clients and farmers throughout India. Their cutting-edge biotech and bovine genomics, embryo genotyping, and in vitro fertilization (IVF) laboratory, combined with professional consulting services, enable dairy farmers to achieve faster genetic advancements. Accuvance is dedicated to empowering dairy farmers with the latest reproductive and bioscience technologies for optimal results.
Public Links of ACCUVANCE LLP
Frequently Asked Questions (FAQ)
When was ACCUVANCE LLP founded?
ACCUVANCE LLP was founded in the year 2021.
Who are the founders of ACCUVANCE LLP?
ACCUVANCE LLP is founded by Kanta Sharma and Neelam Sharma.
What are the focus areas of ACCUVANCE LLP?
Who are ACCUVANCE LLP's competitors?
Possible competitors of ACCUVANCE LLP may include Accumedicare Laboratories Private Limited, Applied Genomics, Biostica Services Private Limited and 7 others.
Get Access to Complete Information
Signup NowYNOS is not associated with any of the entities (organisations / people) mentioned in this page. Information provided here has been curated from multiple public as well as proprietary sources. All efforts have been taken to make it accurate and complete. If details are insufficient or not accurate, kindly suggest edits
Get more information with Govt. Funding
Discover & analyse the best government funding avenues for your startup in India.
Get more information with Debt Funding
Discover Top Loan & Debt Funding Schemes for Startups in India.
Get more information with Incubators
The Ultimate Platform for Finding the Right Incubator and Accelerator.
Get more information with Insight
The most powerful dashboard solution on Indian Startups & Investors.
Try StartupGPT, an AI-Assistant for Founders & Investors
Your conversational companion for Indian Startups, Funding, and much more.
- slide 1 of 8
- slide 2 of 8
- slide 3 of 8
- slide 4 of 8, currently active
- slide 5 of 8
- slide 6 of 8
- slide 7 of 8
- slide 8 of 8